Parkside Financial Bank & Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.11M Buy
25,825
+859
+3% +$99.2K 0.24% 66
2025
Q4
$2.63M Buy
24,966
+887
+4% +$83.3K 0.2% 82
2025
Q3
$2.02M Buy
24,079
+57
+0.2% +$4.7K 0.16% 97
2025
Q2
$1.9M Buy
24,022
+4,144
+21% +$329K 0.2% 95
2025
Q1
$1.78M Sell
19,878
-240
-1% -$22.4K 0.23% 85
2024
Q4
$2M Buy
20,118
+179
+0.9% +$18.5K 0.26% 72
2024
Q3
$2.26M Buy
19,939
+578
+3% +$68.7K 0.32% 63
2024
Q2
$2.4M Sell
19,361
-1,161
-6% -$150K 0.38% 52
2024
Q1
$2.71M Buy
20,522
+1,619
+9% +$200K 0.43% 47
2023
Q4
$2.06M Buy
18,903
+2,556
+16% +$265K 0.37% 54
2023
Q3
$1.68M Sell
16,347
-371
-2% -$40K 0.39% 47
2023
Q2
$1.93M Buy
16,718
+2,258
+16% +$256K 0.46% 39
2023
Q1
$1.54M Buy
14,460
+474
+3% +$51.2K 0.41% 43
2022
Q4
$1.55M Buy
13,986
+1,372
+11% +$140K 0.45% 42
2022
Q3
$1.09M Sell
12,614
-230
-2% -$20.5K 0.35% 51
2022
Q2
$1.17M Sell
12,844
-457
-3% -$40.5K 0.36% 52
2022
Q1
$1.09M Sell
13,301
-859
-6% -$67.7K 0.29% 58
2021
Q4
$1.08M Sell
14,160
-376
-3% -$29.9K 0.27% 66
2021
Q3
$1.09M Buy
14,536
+337
+2% +$25.6K 0.32% 43
2021
Q2
$1.1M Sell
14,199
-8,629
-38% -$642K 0.32% 42
2021
Q1
$1.68M Sell
22,828
-243
-1% -$17.9K 0.51% 35
2020
Q4
$1.8M Buy
23,071
+688
+3% +$52.6K 0.57% 31
2020
Q3
$1.77M Sell
22,383
-3,117
-12% -$244K 0.62% 27
2020
Q2
$1.88M Buy
25,500
+583
+2% +$43.9K 0.62% 24
2020
Q1
$1.83M Buy
24,917
+18
+0.1% +$1.42K 0.69% 24
2019
Q4
$2.16M Buy
24,899
+8,226
+49% +$676K 0.63% 26
2019
Q3
$1.34M Buy
16,673
+1,224
+8% +$98.1K 0.43% 39
2019
Q2
$1.24M Sell
15,449
-967
-6% -$74K 0.4% 37
2019
Q1
$1.3M Sell
16,416
-333
-2% -$24.9K 0.44% 37
2018
Q4
$1.22M Sell
16,749
-157
-0.9% -$11.1K 0.44% 36
2018
Q3
$1.15M Sell
16,906
-575
-3% -$36.6K 0.4% 40
2018
Q2
$1.01M Sell
17,481
-384
-2% -$21.7K 0.38% 45
2018
Q1
$928K Buy
17,865
+243
+1% +$13.1K 0.35% 52
2017
Q4
$946K Sell
17,622
-351
-2% -$19.5K 0.35% 54
2017
Q3
$1.1M Buy
17,973
+100
+0.6% +$6.06K 0.43% 40
2017
Q2
$1.09M Sell
17,873
-1,404
-7% -$85.5K 0.45% 41
2017
Q1
$1.17M Buy
19,277
+182
+1% +$11K 0.5% 39
2016
Q4
$1.07M Buy
19,095
+880
+5% +$51.5K 0.47% 46
2016
Q3
$1.08M Buy
18,215
+402
+2% +$23.5K 0.5% 41
2016
Q2
$979K Sell
17,813
-1,604
-8% -$85.4K 0.48% 44
2016
Q1
$981K Buy
19,417
+501
+3% +$24.5K 0.49% 38
2015
Q4
$953K Buy
18,916
+1,413
+8% +$71.2K 0.47% 38
2015
Q3
$825K Sell
17,503
-12,060
-41% -$641K 0.47% 38
2015
Q2
$1.6M Sell
29,563
-762
-3% -$42.7K 0.85% 28
2015
Q1
$1.66M Buy
30,325
+1,171
+4% +$66.3K 0.89% 25
2014
Q4
$1.58M Sell
29,154
-996
-3% -$55.5K 0.89% 26
2014
Q3
$1.71M Buy
30,150
+285
+1% +$16K 1.03% 21
2014
Q2
$1.65M Sell
29,865
-976
-3% -$53.2K 0.98% 25
2014
Q1
$1.67M Buy
30,841
+1,994
+7% +$103K 1.05% 23
2013
Q4
$1.38M Buy
28,847
+4,097
+17% +$187K 0.93% 31
2013
Q3
$1.13M Sell
24,750
-2,119
-8% -$96.7K 0.88% 35
2013
Q2
$1.19M Buy
+26,869
New +$1.2M 0.94% 31

Other funds holding MRK

Parkside Financial Bank & Trust's MRK Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Merck (MRK) stake by 3.4% in Q1 2026, buying an estimated $99.2K and bringing the position to 25,825 shares worth $3.11M. The position accounts for 0.24% of the portfolio, ranked #66.

Parkside Financial Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Parkside Financial Bank & Trust held 25,825 shares of Merck worth $3.11M as of Q1 2026.
  • Parkside Financial Bank & Trust bought 859 Merck shares in Q1 2026, an estimated $99.2K.
  • Merck made up 0.24% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #66 holding.
  • Parkside Financial Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.